Chemical formula: C₁₆H₁₈FN₃O₂ Molecular mass: 303.331 g/mol PubChem compound: 121892
Retigabine is indicated for:
Population group: only adults (18 years old or older)
Retigabine is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 years or older with epilepsy, where other appropriate combinations with other medicinal products have proved inadequate or have not been tolerated.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Retigabine is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
